A New Year; New US Covid Vax Deaths And Injuries By Brian Simpson

The Centers for Disease Control and Prevention, Vaccine Adverse Event Reporting System (VAERS), the primary government-funded system for reporting adverse vaccine reactions in the U.S., showed a total of 1,000,229 reports of adverse events following COVID vaccines were submitted between December 14, 2020, and December 24, 2021. This included a total of 21,002 reports of deaths and 162,506 reports of serious injuries and  excluding “foreign reports” to VAERS, 709,084 adverse events, including 9,623 deaths and 62,069 serious injuries, were reported.

https://childrenshealthdefense.org/defender/vaers-cdc-covid-vaccine-injuries-fda-pfizer-booster-kids/?utm_source=salsa&eType=EmailBlastContent&eId=08ffe540-bb9b-41ef-a50e-6e7db1d5d616

“The Centers for Disease Control and Prevention on Dec. 31, 2021, released new data showing a total of 1,000,229 reports of adverse events following COVID vaccines were submitted between Dec. 14, 2020, and Dec. 24, 2021, to the Vaccine Adverse Event Reporting System (VAERS). VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S.

The data included a total of 21,002 reports of deaths and 162,506 reports of serious injuries. Excluding “foreign reports” to VAERS, 709,084 adverse events, including 9,623 deaths and 62,069 serious injuries, were reported in the U.S. between Dec. 14, 2020, and Dec. 24, 2021.

Foreign reports are reports received by U.S. manufacturers from their foreign subsidiaries. Under U.S. Food and Drug Administration (FDA) regulations, if a manufacturer is notified of a foreign case report that describes an event that is both serious and does not appear on the product’s labeling, the manufacturer is required to submit the report to VAERS.

Of the 9,623 U.S. deaths reported as of Dec. 24, 20% occurred within 24 hours of vaccination, 25% occurred within 48 hours of vaccination and 61% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.

In the U.S., 499.7 million COVID vaccine doses had been administered as of Dec. 23. This includes 291 million doses of Pfizer, 190 million doses of Moderna and 18 million doses of Johnson & Johnson (J&J).

Every Friday, VAERS publishes vaccine injury reports received as of a specified date. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed. Historically, VAERS has been shown to report only 1% of actual vaccine adverse events.

U.S. VAERS data from Dec. 14, 2020, to Dec. 24, 2021, for 5- to 11-year-olds show:

• 5,706 adverse events, including 114 rated as seriousand 2 reported deaths.
• 11 reportsof myocarditis and pericarditis (heart inflammation).
• 14 reportsof blood clotting disorders.

U.S. VAERS data from Dec. 14, 2020, to Dec. 24, 2021, for 12- to 17-year-olds show:  

• 25,802 adverse events, including 1,506 rated as seriousand 34 reported deaths.

The most recent death involves a previously healthy 15-year-old girl from Wisconsin (VAERS I.D. 1963633), who experienced a cerebral and intraventricular hemorrhage secondary to a ruptured aneurysm. She also tested positive for SARS-CoV-2 despite having been fully vaccinated.

• 61 reportsof anaphylaxis among 12- to 17-year-olds where the reaction was life-threatening, required treatment or resulted in death — with 96% of cases
  attributed to Pfizer’s vaccine.
• 579 reportsof myocarditis and pericarditis with 568 cases attributed to Pfizer’s vaccine.
• 146 reportsof blood clotting disorders, with all cases attributed to Pfizer.

U.S. VAERS data from Dec. 14, 2020, to Dec. 10, 2021, for all age groups combined, show:

• 19% of deaths were related to cardiac disorders.
• 54% of those who died were male, 41% were female and the remaining death reports did not include the gender of the deceased.
• The average ageof death was 72.3.
• As of Dec. 24, 4,692 pregnant womenreported adverse events related to COVID vaccines, including 1,487 reports of miscarriage or premature birth.
• Of the 3,358 cases of Bell’s Palsyreported, 51% were attributed to Pfizer vaccinations, 41% to Moderna and 8% to J&J.
• 815 reports of Guillain-Barré syndrome(GBS), with 41% of cases attributed to Pfizer, 29% to Moderna and 28% to J&J.
• 2,241 reportsof anaphylaxis where the reaction was life-threatening, required treatment or resulted in death.
• 12,070 reportsof blood clotting disorders in the U.S. Of those, 5,341 reports were attributed to Pfizer, 4,302 reports to Moderna and 2,275 reports to J&J.
• 3,405 casesof myocarditis and pericarditis with 2,379 cases attributed to Pfizer, 1,197 cases to Moderna and 152 cases to J&J’s COVID vaccine.

FDA clears Pfizer boosters for 12- to 15-year-olds, bypasses experts 

The FDA today amended Emergency Use Authorization (EUA) for Pfizer’s COVID vaccine expanding eligibility for boosters to children 12 through 15 years of age.

The agency did not consult its expert panel of vaccine advisors, who in September, overwhelmingly rejected boosters for healthy people 16 and older.

The FDA also shortened the time for both adolescents and adults to receive a booster from six months to five months after receiving a second dose and authorized a third shot for immunocompromised children aged 5 to 11.

Dr. Peter Marks, director of the Center for Biologics Evaluation and Research at the FDA, said in a statement the agency made its decision because a third dose “may help provide better protection against both the Delta and Omicron variants.”

The FDA said it reviewed real-world data from Israel of more than 6,300 individuals 12- to 15-years-old who received a booster at least five months after their second Pfizer dose and found no serious safety concerns.

Likewise, additional data showed no problems giving anyone eligible for a Pfizer booster an extra dose at five months instead of six, the Associated Press reported.

The FDA said it will continue to review the information and communicate with the public if data emerges suggesting booster doses are needed for the younger pediatric population.”